Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …

In the last few decades, targeting cancer by the use of dietary phytochemicals has gained
enormous attention. The plausible reason and believe or mind set behind this fact is …

Lung cancer is the leading cause of cancer-related deaths worldwide and non-small cell
lung cancer (NSCLC) accounts for more than 80% of all lung cancer cases. Recent …

Currently, early detection of lung cancer relies on the characterisation of images generated
from computed tomography (CT). However, lung tissue biopsy, a highly invasive surgical …

Cancer prevalence and its rate of incidence are constantly rising since the past few
decades. Owing to the toxicity of present-day antineoplastic drugs, it is imperative to explore …

Simple Summary Biomarkers for the prediction and efficacy of therapies are an urgent
necessity for lung cancer patients. In this article, we summarize genomic and proteomic …

Dysregulated expression profiles of microRNAs (miRNAs) have been observed in several
types of cancer, including non-small cell lung cancer (NSCLC); however, the diagnostic and …

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with
fewer treatment options than other types of invasive breast cancer due to the loss of the …

Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and is a malignant
condition resistant to advanced-stage treatment. Despite the advancement in detection and …

Improvement of breast cancer (BC) patient's outcome is directly related to early detection.
However, there is still a lack of reliable biomarkers for diagnosis, prognosis and, treatment …